Table 5. Multivariate logistic regression for T2DM microvascular complications.
| Variables | Diabetic retinopathy | Diabetic neuropathy | Diabetic nephropathy | |||||
|---|---|---|---|---|---|---|---|---|
| OR (95% CI) | P | OR (95% CI) | P | OR (95% CI) | P | |||
| Gender (female) | 1.11 (0.95–1.31) | 0.178 | – | – | – | – | ||
| Age | 1.00 (1.00–1.01) | 0.053 | 1.00 (0.99–1.00) | 0.670 | 0.99 (0.98–1.01) | 0.637 | ||
| Smoking | – | – | 1.70 (1.41–2.06) | <0.001 | – | – | ||
| Family history of T2DM | – | – | 1.30 (1.12–1.51) | <0.001 | 1.12 (9.15–1.37) | 0.271 | ||
| Duration | 1.05 (1.04–1.06) | <0.001 | 1.04 (1.03–1.05) | <0.001 | 1.05 (1.04–1.07) | <0.001 | ||
| Insulin use | 1.81 (1.42–2.31) | <0.001 | 1.44 (1.14–1.82) | 0.002 | 1.90 (1.41–2.56) | <0.001 | ||
| Hypertension | 2.01 (1.69–2.40) | <0.001 | 3.01 (2.57–3.52) | <0.001 | 2.48 (1.98–3.10) | <0.001 | ||
| Dyslipidemia | 2.13 (1.76–2.57) | <0.001 | 1.47 (1.23–1.76) | <0.001 | 3.37 (2.72–4.18) | <0.001 | ||
| Regular exercise | – | – | 0.68 (0.58–0.80) | <0.001 | 0.73 (0.58–0.90) | 0.005 | ||